期刊文献+

DNA微阵列芯片法用于检测结核分枝杆菌耐药性的研究 被引量:2

Research on DNA microarray chip method for detecting drug resistance of Mycobacterium tuberculosis
下载PDF
导出
摘要 目的通过与传统的比例法在结核分枝杆菌耐药性检测的比较,评价DNA微阵列法用于检测结核分枝杆菌耐药性的可行性。方法随机抽取本院2012年1月至2013年3月从临床标本中分离培养所得的结核分枝杆菌54株,通过DNA微阵列法和比例法分别进行异烟肼和利福平的耐药性检测并对结果进行比较分析。结果以比例法为金标准,DNA微阵列法对异烟肼和利福平的耐药检测结果与比例法的符合率分别为75.0%、91.0%。结论 DNA微阵列技术适用于临床一线耐药结核分枝杆菌的快速筛查。 Objective To evaluate the feasibility of the DNA microarray method used in detecting the drug resistance of Myco-bacterium tuberculosis by comparing the traditional proportion method and the DNA microarray method for detecting the drug re-sistance of Mycobacterium tuberculosis.Methods 54 strains of Mycobacterium tuberculosis isolated from clinical specimens in our hospital from January 2012 to March 2013 were randomly extracted and their resistance to isonicotinic acid hydrazide (INH)and rifampicin(RFP)was detected by the DNA microarray method and the proportion method.The detection results were performed the comparative analysis.Results With the proportion method as the golden standard,the coincidence rates of the DNA microarray method for detecting the Mycobacterium tuberculosis resistance to INH and RFP were 75% and 91.0% respectively.Conclusion The DNA microarray technique is suitable for the rapid screening of clinical first-line drug resistant Mycobacterium tuberculosis.
出处 《国际检验医学杂志》 CAS 2014年第14期1910-1913,共4页 International Journal of Laboratory Medicine
基金 山东省科技发展计划项目(2006GG2202001)
关键词 DNA微阵列 结核分枝杆菌 核酸杂交 药物耐受性 突变 DNA microarray Mycobacterium tuberculosis nucleotide hybridization drug resistance mutation
  • 相关文献

参考文献10

  • 1Lnnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development [J]. Lancet,2010,375(9728):1814 -1829.
  • 2World Health Organization. WHO Report: Global Tuberculosis Control 2012[S]. 2012.
  • 3中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008)[M].北京:人民卫生出版社,2010:49.
  • 4Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy,and effectiveness of decentralized use of the Xpert MTB/ RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study[J]. Lancet, 2011,377 ( 9776 ) : 1495-1505.
  • 5Guo Y, Zhou Y, Wang C, et al. Rapid, accurate determination of muitidrug resistance in M. tuberculosis isolates and sputum using a bioehip system[J]. Int J Tuberc lung Dis,2009,13(7) 914-920.
  • 6Chaoui I,Sabouni R,Kourout M,et al. Analysis of isoniazid,stteptomycin and ethambutol resistance in Myeobacterium tuberculosis of isonizid, streptomycin and ethambutol resistance in Mycobacte rium tuberculosis isolates from Morocco[J]. J infect Dev Ctries. 2009 3(4),278-284.
  • 7Pham M, Lemberg DA, Day AS. Probiotics: sorting the evidence from the Myths[J]. Med J Aust,2008,188(5) :304 -308.
  • 8Science Direct. Rifampin[J]. Tuberculosis, 2008,88 : 151-154.
  • 9Luckner SR,Liu N, am Ende CW, et al. A slow, tight binding in- hibitor of InhA, the enoyl-acyl carrier protein reduetase from Mycobacterium tuberculosis[J]. J Biol Chem, 2010,285 ( 19 ) : 14330 -14337.
  • 10张太松,李明.分子诊断技术在耐多药结核分枝杆菌检测中的应用进展[J].分子诊断与治疗杂志,2009,1(2):129-134. 被引量:11

二级参考文献23

  • 1Manissero D,Fernandez de la Hoz K.Surveillance methods and case definition for extensively drug resistant TB(XDR-TB)and relevance to Europe:summary update. Euro Surveillance Bulletin Europeen sur les Maladies Transmissibles . 2006
  • 2Vier H,Schaberg T,Gillissen A.Emergence extensive drug resistance tuberculosis(XDR). Pneumologie . 2007
  • 3Shenai S,Rodrigues C,Mehta A.Rapid speciation of15clinically relevant mycobacteria with simultaneous detection of resistance to rifampin,isoniazid,and streptomycin in Mycobacterium tuberculosis complex. International Journal of Infectious Diseases . 2009
  • 4Costa ER,Ribeiro MO,Silva MS,et al.Correlations of mutations in katG,oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiology . 2009
  • 5Evans J,Stead MC,Nicol MP,et al.Rapid genotypic assays to identify drug-resistant mycobacterium tuberculosis in South Africa. Journal of Antimicrobial Chemotherapy . 2009
  • 6Shah NS,Lan NT,Huyen MN,et al.Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam. International Journal of Tuberculosis and Lung Disease . 2009
  • 7Lacoma A,Garcia-Sierra N,Prat C,et al.GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in mycobacterium tuberculosis strains and clinical samples. Journal of Clinical Microbiology . 2008
  • 8Espasa MGJ,Alcaide F,Lonca J,et al.Use of real time PCR for direct detection in clinical samples of genetic polimorphisms causing resistance to isoniazid and rifampicin in mycobacterium tuberculosis. Milan XII European Congress of Clinical Microbiology and Infectious Diseases . 2002
  • 9Evans JT,Parveen A,Smith GE,et al.Application of denaturing HPLC to rapidly identify rifampicin-resistant mycobacterium tuberculosis in low-and high-prevalence areas. Journal of Antimicrobial Chemotherapy . 2009
  • 10Cavusoglu C,Hilmioglu S,Guneri S,et al.Characterization of rpoB mutations in rifampin-resistant clinical isolates of mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. Journal of Clinical Microbiology . 2002

共引文献32

同被引文献19

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部